Product NDC: | 0409-7444 |
Proprietary Name: | Cimetidine |
Non Proprietary Name: | CIMETIDINE HYDROCHLORIDE |
Active Ingredient(s): | 150 mg/mL & nbsp; CIMETIDINE HYDROCHLORIDE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-7444 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074344 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110708 |
Package NDC: | 0409-7444-01 |
Package Description: | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-7444-01) > 2 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 0409-7444-01 |
Proprietary Name | Cimetidine |
Package Description | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-7444-01) > 2 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 0409-7444 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CIMETIDINE HYDROCHLORIDE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20110708 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | CIMETIDINE HYDROCHLORIDE |
Strength Number | 150 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |